Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation-Reference-Cited by-同舟云学术

Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation

Published:2013-08-09 Issue:8 Volume:8 Page:e72419
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Teixeira Ana L.,Gomes Mónica,Nogueira Augusto,Azevedo Andreia S.,Assis Joana,Dias Francisca,Santos Juliana I.,Lobo Francisco,Morais António,Maurício Joaquina,Medeiros Rui

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;J Ferlay;Int J Cancer,2010

2. Redefining hormone sensitive disease in advanced prostate cancer;X Hou;Adv Urol,2012

3. Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3;L Chen;Clin Cancer Res,2011

4. Castration-resistant prostate cancer: targeted therapies and individualized treatment;R Aggarwal;Oncologist,2011

5. Transforming growth factor beta (TGF-B) and inflammation in cancer;B Bierie;Cytokine Growth Factor Rev,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer;Cancer Cell International;2023-10-19

2. Analysis of Genetic Biomarkers, Polymorphisms in ADME-Related Genes and their Impact on Pharmacotherapy for Prostate Cancer;2023-08-17

3. AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes;Pharmacogenomics;2021-11

4. Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer;Frontiers in Oncology;2021-05-25

5. Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer;JMA Journal;2021